Suppliers / Huangshan Bonsun Pharmaceuticals

Huangshan Bonsun Pharmaceuticals

China Updated 9 July 2026

Huangshan Bonsun Pharmaceuticals is an API manufacturer based in China. It holds 3 valid CEPs across a filed portfolio of 3 molecules.

0
active US DMFs
3
valid CEPs
2
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Shexian, China Not on file
Huangshan, China Not on file

What they file, and where

Molecule Regulators Docs
Copovidone EDQM 1
Crospovidone EDQM 1
Povidone EDQM 1

Also appears on these molecule pages

Questions about Huangshan Bonsun Pharmaceuticals

Does Huangshan Bonsun Pharmaceuticals hold a US DMF or a CEP?
Huangshan Bonsun Pharmaceuticals holds 3 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Huangshan Bonsun Pharmaceuticals manufacture?
2 registered sites are on record, in China (Shexian and Huangshan). Every site is listed on this page with the register it came from.
What does Huangshan Bonsun Pharmaceuticals make?
3 molecules are on record against Huangshan Bonsun Pharmaceuticals, including Copovidone, Crospovidone and Povidone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Huangshan Bonsun Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability